Ö. Ataman
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
- Oncology 10
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Shampa Das (2 shared papers)David M. Wilson (2 shared papers)Paul K. Stockman (2 shared papers)Geoffrey I. Shapiro (2 shared papers)Emile E. Voest (1 shared paper)Petronella O. Witteveen (1 shared paper)Martijn P. Lolkema (1 shared paper)Jan H.M. Schellens (1 shared paper)
- Journals
- Radiotherapy and Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Clinical Oncology (2 papers)European Archives of Oto-Rhino-Laryngology (2 papers)Investigational New Drugs (1 paper)
- Partner nations
- United KingdomTürkiyeUnited States
In The Last Decade
Ö. Ataman
23 papers receiving 531 citations
Peers
Comparison fields: 5 of 63
- Otorhinolaryngology 64
- Oncology 313
- Cell Biology 120
- Hematology 78
- Pulmonary and Respiratory Medicine 181
Countries citing papers authored by Ö. Ataman
This map shows the geographic impact of Ö. Ataman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ö. Ataman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ö. Ataman more than expected).
Fields of papers citing papers by Ö. Ataman
This network shows the impact of papers produced by Ö. Ataman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ö. Ataman. The network helps show where Ö. Ataman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ö. Ataman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 96 | |
| 2 | 2010 | 85 | |
| 3 | 2012 | 61 | |
| 4 | 2020 | 54 | |
| 5 | 2007 | 30 | |
| 6 | 2012 | 28 | |
| 7 | 2008 | 25 | |
| 8 | 2014 | 23 | |
| 9 | 2015 | 21 | |
| 10 | 2004 | 20 | |
| 11 | 2016 | 20 | |
| 12 | 2004 | 15 | |
| 13 | 2001 | 14 | |
| 14 | 2008 | 14 | |
| 15 | 2005 | 12 | |
| 16 | 2001 | 9 | |
| 17 | 2009 | 3 | |
| 18 | 2016 | 3 | |
| 19 | 2013 | 2 | |
| 20 | KANSER HASTALARINDA TIP DIŞI TEDAVİ YÖNTEMLERİNİN ARAŞTIRILMASI | 2000 | 1 |
About Ö. Ataman
Ö. Ataman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Otorhinolaryngology and Radiation, having authored 23 papers that have together received 539 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Protein Degradation and Inhibitors (4 papers), Head and Neck Cancer Studies (4 papers), Advanced Radiotherapy Techniques (4 papers), Multiple Myeloma Research and Treatments (4 papers), Peptidase Inhibition and Analysis (3 papers), Medical Imaging Techniques and Applications (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Otorhinolaryngology (64 citations), Oncology (313 citations), Cell Biology (120 citations), Hematology (78 citations) and Pulmonary and Respiratory Medicine (181 citations). Ö. Ataman has collaborated with scholars based in United Kingdom, Türkiye and United States. Frequent co-authors include Shampa Das, David M. Wilson, Paul K. Stockman, Geoffrey I. Shapiro, Emile E. Voest, Petronella O. Witteveen, Martijn P. Lolkema, Jan H.M. Schellens, David S. Boss and Bonne Biesma. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, European Archives of Oto-Rhino-Laryngology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.